| Jose Martinez, MD | |
|
801 W 38th St, Suite 200, Austin, TX 78705-1169 | |
| (512) 451-0103 | |
| (512) 451-2741 |
| Full Name | Jose Martinez |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 36 Years |
| Location | 801 W 38th St, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679545370 | NPI | - | NPPES |
| 139156717 | Medicaid | TX | |
| 883205 | Other | TX | BCBS TX |
| 139156713 | Medicaid | TX | |
| 180022149 | Other | TX | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | H6411 (Texas) | Primary |
| 207WX0107X | Ophthalmology - Retina Specialist | H6411 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Hills Surgical Hospital | Austin, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Austin Retina Associates Pllc | 2163497801 | 12 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload ADC technology, today announced the presentation of the first clinical data with the Company's IMGN853 product candidate.
One of the bi-products of the COVID-19 pandemic has been a decrease in the number of patients seeing or talking to their GPs, as findings from a Institute of Fiscal Studies report identified late last year.
Even patients with insurance are finding that specialty drugs can quickly eat a hole in their wallets because insurers are often putting them in a special tier and demanding high consumer co-payments. Also, the State Department is getting rid of the "transgender exclusion" in it largest health plan, and some consumer advocates are suggesting that people getting coverage on the health marketplaces be allowed to get "wrap-around" plans through their employers.
At a presentation hosted by the Global Health Council on Thursday at the University of Washington, Christopher Murray and Michael Hanlon from the Institute for Health Metrics and Evaluation provided an update on global development assistance for health, the Center for Global Health Policy's "Science Speaks" blog reports.
Microbiologist Karl Klose, a professor in the UTSA College of Sciences' Department of Biology and a member of the South Texas Center for Emerging Infectious Diseases, has received a contract from the U.S. Department of Defense (DOD) to conduct research that would bring scholars one step closer to developing a vaccine against tularemia.
› Verified 4 days ago
| Entity Name | Austin Retina Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033183561 PECOS PAC ID: 2163497801 Enrollment ID: O20040827000054 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload ADC technology, today announced the presentation of the first clinical data with the Company's IMGN853 product candidate.
One of the bi-products of the COVID-19 pandemic has been a decrease in the number of patients seeing or talking to their GPs, as findings from a Institute of Fiscal Studies report identified late last year.
Even patients with insurance are finding that specialty drugs can quickly eat a hole in their wallets because insurers are often putting them in a special tier and demanding high consumer co-payments. Also, the State Department is getting rid of the "transgender exclusion" in it largest health plan, and some consumer advocates are suggesting that people getting coverage on the health marketplaces be allowed to get "wrap-around" plans through their employers.
At a presentation hosted by the Global Health Council on Thursday at the University of Washington, Christopher Murray and Michael Hanlon from the Institute for Health Metrics and Evaluation provided an update on global development assistance for health, the Center for Global Health Policy's "Science Speaks" blog reports.
Microbiologist Karl Klose, a professor in the UTSA College of Sciences' Department of Biology and a member of the South Texas Center for Emerging Infectious Diseases, has received a contract from the U.S. Department of Defense (DOD) to conduct research that would bring scholars one step closer to developing a vaccine against tularemia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jose Martinez, MD 801 W 38th St, Suite 200, Austin, TX 78705-1169 Ph: (512) 451-0103 | Jose Martinez, MD 801 W 38th St, Suite 200, Austin, TX 78705-1169 Ph: (512) 451-0103 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload ADC technology, today announced the presentation of the first clinical data with the Company's IMGN853 product candidate.
One of the bi-products of the COVID-19 pandemic has been a decrease in the number of patients seeing or talking to their GPs, as findings from a Institute of Fiscal Studies report identified late last year.
Even patients with insurance are finding that specialty drugs can quickly eat a hole in their wallets because insurers are often putting them in a special tier and demanding high consumer co-payments. Also, the State Department is getting rid of the "transgender exclusion" in it largest health plan, and some consumer advocates are suggesting that people getting coverage on the health marketplaces be allowed to get "wrap-around" plans through their employers.
At a presentation hosted by the Global Health Council on Thursday at the University of Washington, Christopher Murray and Michael Hanlon from the Institute for Health Metrics and Evaluation provided an update on global development assistance for health, the Center for Global Health Policy's "Science Speaks" blog reports.
Microbiologist Karl Klose, a professor in the UTSA College of Sciences' Department of Biology and a member of the South Texas Center for Emerging Infectious Diseases, has received a contract from the U.S. Department of Defense (DOD) to conduct research that would bring scholars one step closer to developing a vaccine against tularemia.
› Verified 4 days ago
Dr. Kristen Michelle Hawthorne, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2610 S Ih 35, Austin, TX 78704 Phone: 512-443-9715 Fax: 512-443-9845 | |
Saradha Chexal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy Ste 460, Austin, TX 78705 Phone: 512-454-5851 | |
Dr. John David Fisher, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2901 Montopolis Dr, Austin, TX 78741 Phone: 512-389-6571 Fax: 512-389-6511 | |
Dr. Clio Armitage Harper Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 801 W 38th St, Suite 200, Austin, TX 78705 Phone: 512-451-0103 Fax: 512-451-2741 | |
Dr. Nadja Ivette Torres, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2610 S Ih 35, Austin, TX 78704 Phone: 512-443-9715 Fax: 512-443-9845 | |
Fuad Makkouk, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9707 Anderson Mill Rd Ste 230, Austin, TX 78750 Phone: 512-693-9363 | |
Irina Volosko, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3410 Far West Blvd Ste 140, Austin, TX 78731 Phone: 512-427-1107 Fax: 512-427-1207 |